Quoin Pharmaceuticals, Ltd. (QNRX) Tops Q4 EPS by 10c

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q4 EPS of ($0.41), $0.10 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Financial Select Sector SPDR ETF (XLF) spreader of 20K contracts of July 31 weekly 57 and 59 calls into bank earnings season
• Quoin gets FDA clearance for Phase 2 trial of QRX003 in rare skin disease